Literature DB >> 15536115

Human monocytic ehrlichiosis.

John H Stone1, Kerry Dierberg, Ghazaleh Aram, J Stephen Dumler.   

Abstract

A 56-year-old man with a history of Wegener granulomatosis presented with 6 days of sinus congestion, fever, malaise, myalgias, episcleritis, and a morbilliform rash. An exacerbation of Wegener granulomatosis was the principal concern because of the frequency of flares in that disease. The patient developed acute renal failure, thrombocytopenia, transaminitis, and, finally, severe myocarditis that led to congestive heart failure. Additional history-taking and the evolution of his clinical features led to empirical treatment with doxycycline for human monocytic ehrlichiosis (HME). The diagnosis of HME was confirmed by both a polymerase chain reaction assay for Ehrlichia chaffeensis and by the demonstration of morulae within peripheral blood mononuclear cells. The patient improved promptly following institution of doxycycline, and his cardiac function returned to normal over a period of 4 months.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15536115     DOI: 10.1001/jama.292.18.2263

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  11 in total

1.  Pattern Recognition Receptors in Innate Immunity to Obligate Intracellular Bacteria.

Authors:  James R Fisher; Zachary D Chroust; Florence Onyoni; Lynn Soong
Journal:  Zoonoses (Burlingt)       Date:  2021-10-25

2.  Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge.

Authors:  Nagaraja R Thirumalapura; Heather L Stevenson; David H Walker; Nahed Ismail
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

3.  Experimental infection of dairy calves with Ehrlichia chaffeensis.

Authors:  Jose R C Delos Santos; Kirsten Boughan; William G Bremer; Brian Rizzo; John J Schaefer; Yasuko Rikihisa; Glen R Needham; L A Capitini; David E Anderson; Michael Oglesbee; S A Ewing; Roger W Stich
Journal:  J Med Microbiol       Date:  2007-12       Impact factor: 2.472

4.  Relative importance of T-cell subsets in monocytotropic ehrlichiosis: a novel effector mechanism involved in Ehrlichia-induced immunopathology in murine ehrlichiosis.

Authors:  Nahed Ismail; Emily C Crossley; Heather L Stevenson; David H Walker
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

5.  Pathologic evidence of ehrlichiosis in calves inoculated with Ehrlichia chaffeensis.

Authors:  Jose R C Delos Santos; Michael Oglesbee; Yasuko Rikihisa; R W Stich
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

6.  Ehrlichia infection of the central nervous system.

Authors:  Igen Hongo; Karen C Bloch
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.972

7.  Fatal Monocytic Ehrlichiosis in Woman, Mexico, 2013.

Authors:  Carolina G Sosa-Gutierrez; Fortino Solorzano-Santos; David H Walker; Javier Torres; Carlos A Serrano; Guadalupe Gordillo-Perez
Journal:  Emerg Infect Dis       Date:  2016-05       Impact factor: 6.883

8.  Myocarditis after trimethoprim/sulfamethoxazole treatment for ehrlichiosis.

Authors:  Seema U Nayak; Gary L Simon
Journal:  Emerg Infect Dis       Date:  2013-12       Impact factor: 6.883

9.  Ehrlichia chaffeensis infection in the reservoir host (white-tailed deer) and in an incidental host (dog) is impacted by its prior growth in macrophage and tick cell environments.

Authors:  Arathy D S Nair; Chuanmin Cheng; Deborah C Jaworski; Lloyd H Willard; Michael W Sanderson; Roman R Ganta
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

10.  Is it a Drug or a Bug? A Case of Chemotherapy and Immune Modulators Complicating the Diagnosis of Ehrlichiosis.

Authors:  Mason E Uvodich; Victoria Poplin; Heather J Male
Journal:  Kans J Med       Date:  2018-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.